Histidine rich protein-2 diagnostic test for cerebral malaria

Details for Australian Patent Application No. 2011232632 (hide)

Owner Board of Trustees of Michigan State University

Inventors Seydel, Karl B.; Taylor, Terrie E.

Agent Davies Collison Cave

Pub. Number AU-A-2011232632

PCT Pub. Number WO2011/119609

Priority 61/316,643 23.03.10 US

Filing date 22 March 2011

Wipo publication date 29 September 2011

International Classifications

G01N 33/569 Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

1 November 2012 PCT application entered the National Phase

  PCT publication WO2011/119609 Priority application(s): WO2011/119609

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011232633-(20S)-2-methylene-19-nor-22dimethyl-1alpha,25dihydroxyvitamin D3 and (20R)-2-methylene-19-nor-22dimethyl-1a,25-hydroxyvitamin D3

2011232628-Morphinane derivatives containing a carboxamide group as opioid receptor ligands